Kaizen Financial Strategies - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.

Quarter-by-quarter ownership
Kaizen Financial Strategies ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$223,648
-5.8%
3,2000.0%0.19%
-6.9%
Q2 2023$237,472
+2.3%
3,200
-7.2%
0.20%
-11.4%
Q4 2022$232,185
-19.1%
3,450
-54.0%
0.23%
-19.1%
Q2 2022$287,000
-7.4%
7,5000.0%0.28%
+16.5%
Q1 2022$310,000
+9.5%
7,5000.0%0.24%
+14.6%
Q4 2021$283,000
+14.6%
7,5000.0%0.21%
+6.5%
Q3 2021$247,0007,5000.20%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 758,794$53,032,11365.14%
Fairmount Funds Management LLC 2,341,238$163,629,12419.69%
Ally Bridge Group (NY) LLC 110,600$7,729,8349.07%
RTW INVESTMENTS, LP 4,489,596$313,777,8646.62%
SVB FINANCIAL GROUP 33,849$2,365,7074.45%
BVF INC/IL 2,131,100$148,942,5794.02%
Altium Capital Management LP 92,000$6,429,8803.35%
Tri Locum Partners LP 142,510$9,960,0243.18%
TANG CAPITAL MANAGEMENT LLC 320,000$22,364,8003.16%
Deep Track Capital, LP 1,140,745$79,726,6683.08%
View complete list of AXSOME THERAPEUTICS INC shareholders